Xenon MRI and Progressive ILD

PHASE2Active, not recruitingINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

July 19, 2022

Primary Completion Date

November 3, 2025

Study Completion Date

August 31, 2026

Conditions
Idiopathic Pulmonary FibrosisProgressive Pulmonary Fibrosis
Interventions
DRUG

Hyperpolarized 129 Xenon Gas Comparing Progressive Pulmonary Fibrosis Treatment

Whether magnetic resonance imaging (MRI) using inhaled hyper-polarized 129 Xenon gas can help visualize impaired lung function to detect changes over time in Progressive Pulmonary Fibrosis

Trial Locations (1)

27710

Duke University, Durham

Sponsors

Lead Sponsor

Collaborators (1)

All Listed Sponsors
collaborator

Boehringer Ingelheim

INDUSTRY

lead

Duke University

OTHER

NCT05241275 - Xenon MRI and Progressive ILD | Biotech Hunter | Biotech Hunter